169 related articles for article (PubMed ID: 15201477)
1. Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4.
Burkhardt MS; Foster JK; Laws SM; Baker LD; Craft S; Gandy SE; Stuckey BG; Clarnette R; Nolan D; Hewson-Bower B; Martins RN
J Alzheimers Dis; 2004 Jun; 6(3):221-8. PubMed ID: 15201477
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term, low-dose sex hormone replacement therapy on hippocampus and cognition of postmenopausal women of different apoE genotypes.
Yue Y; Hu L; Tian QJ; Jiang JM; Dong YL; Jin ZY; Cheng YH; Hong X; Ge QS; Zuo PP
Acta Pharmacol Sin; 2007 Aug; 28(8):1129-35. PubMed ID: 17640473
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy to maintain cognitive function in women with dementia.
Hogervorst E; Yaffe K; Richards M; Huppert F
Cochrane Database Syst Rev; 2002; (3):CD003799. PubMed ID: 12137718
[TBL] [Abstract][Full Text] [Related]
5. Accelerated memory decline in Alzheimer's disease with apolipoprotein epsilon4 allele.
Hirono N; Hashimoto M; Yasuda M; Kazui H; Mori E
J Neuropsychiatry Clin Neurosci; 2003; 15(3):354-8. PubMed ID: 12928512
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
[TBL] [Abstract][Full Text] [Related]
7. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.
Bondi MW; Salmon DP; Galasko D; Thomas RG; Thal LJ
Psychol Aging; 1999 Jun; 14(2):295-303. PubMed ID: 10403716
[TBL] [Abstract][Full Text] [Related]
9. ABCA7 polymorphisms correlate with memory impairment and default mode network in patients with APOEε4-associated Alzheimer's disease.
Chang YT; Hsu SW; Huang SH; Huang CW; Chang WN; Lien CY; Lee JJ; Lee CC; Chang CC
Alzheimers Res Ther; 2019 Dec; 11(1):103. PubMed ID: 31831047
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E (APOE) ε4 and episodic memory decline in Alzheimer's disease: A review.
El Haj M; Antoine P; Amouyel P; Lambert JC; Pasquier F; Kapogiannis D
Ageing Res Rev; 2016 May; 27():15-22. PubMed ID: 26876367
[TBL] [Abstract][Full Text] [Related]
11. Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men.
Burkhardt MS; Foster JK; Clarnette RM; Chubb SA; Bruce DG; Drummond PD; Martins RN; Yeap BB
J Clin Endocrinol Metab; 2006 Mar; 91(3):1168-72. PubMed ID: 16368754
[TBL] [Abstract][Full Text] [Related]
12. Association of the apolipoprotein E genotype with memory performance and executive functioning in cognitively intact elderly.
Luck T; Then FS; Luppa M; Schroeter ML; Arélin K; Burkhardt R; Thiery J; Löffler M; Villringer A; Riedel-Heller SG
Neuropsychology; 2015 May; 29(3):382-387. PubMed ID: 25365563
[TBL] [Abstract][Full Text] [Related]
13. Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype.
Lange KL; Bondi MW; Salmon DP; Galasko D; Delis DC; Thomas RG; Thal LJ
J Int Neuropsychol Soc; 2002 Nov; 8(7):943-55. PubMed ID: 12405546
[TBL] [Abstract][Full Text] [Related]
14. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
Klages JD; Fisk JD; Rockwood K
Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
[TBL] [Abstract][Full Text] [Related]
15. Impact of APOE status on cognitive maintenance in healthy elderly persons.
Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
[TBL] [Abstract][Full Text] [Related]
16. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.
Almeida S; Fiegenbaum M; de Andrade FM; Osório-Wender MC; Hutz MH
Maturitas; 2006 May; 54(2):119-26. PubMed ID: 16242874
[TBL] [Abstract][Full Text] [Related]
17. Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy use.
Jacobs EG; Kroenke C; Lin J; Epel ES; Kenna HA; Blackburn EH; Rasgon NL
PLoS One; 2013; 8(2):e54713. PubMed ID: 23418430
[TBL] [Abstract][Full Text] [Related]
18. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
19. Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?
Small BJ; Graves AB; McEvoy CL; Crawford FC; Mullan M; Mortimer JA
Neurology; 2000 Jun; 54(11):2082-8. PubMed ID: 10851367
[TBL] [Abstract][Full Text] [Related]
20. The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review.
Zec RF; Trivedi MA
Neuropsychol Rev; 2002 Jun; 12(2):65-109. PubMed ID: 12371603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
